Skip to main content
. 2023 Mar 11;15(6):1724. doi: 10.3390/cancers15061724

Figure 1.

Figure 1

Overexpression of miR-153-3p enhances the chemosensitivity of breast cancer cells to doxorubicin. Cell viability was analyzed after 24 h via the MTT assay in MCF-7 (A,C) and MDA-MB-231 (B,D) cells.